Paper39019262
Leveraging artificial intelligence in vaccine development: A narrative review.
Olawade DB and 6 others. J Microbiol Methods, 2024. Cited by 92 papers, by iCite.
Cite this record
ConductScience Library. Leveraging artificial intelligence in vaccine development: A narrative review. Papers, record 39019262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39019262
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Artificial Intelligence | Major topic |
| Vaccine Development | Major topic |
| Vaccines | Major topic |
| Humans | |
| Adjuvants, Immunologic | |
| Epitopes | |
| Animals | |
| Antigens | |
| Machine Learning |
Source PubMed
Cited by77
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42944004 | Integrative Machine Learning and Immunoinformatics-Guided Design and In Silico Validation of a Multiepitope DNA Vaccine Against Avian Metapneumovirus. | Viruses | 2026 | https://conductscience.org/library/papers/42944004 | PubMed |
| 42903960 | Decoding vaccine-induced immunity: From systems vaccinology to artificial intelligence-driven precision vaccines. | Hlife | 2026 | https://conductscience.org/library/papers/42903960 | PubMed |
| 42807370 | Vaccines for microbial eye diseases in the era of data science: opportunities and challenges. | Front Immunol | 2026 | https://conductscience.org/library/papers/42807370 | PubMed |
| 42699333 | Climate change impact on disease emergence and antimicrobial resistance: A perspective on transmission and detection. | iScience | 2026 | https://conductscience.org/library/papers/42699333 | PubMed |
| 42667378 | In silico pharmacological evaluation of a multi-epitope vaccine candidate targeting the G1 and G2 glycoproteins of Oropouche virus via TLR3 interaction. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42667378 | PubMed |
| 42599520 | Emerging and Re-Emerging Viral Infections in Poultry: Integrating Traditional and AI-Based Control Strategies. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42599520 | PubMed |
| 42528707 | Artificial intelligence in vaccine development: applications, implementation, and future directions. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42528707 | PubMed |
| 42506634 | Vaccine Therapy for the Management of Penile Cancer: Evidence, Opportunities and Challenges. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42506634 | PubMed |
| 42420694 | Plant Biofactories for Vaccination: Progress in Edible Vaccine Technologies as a Sustainable Approach to Global Immunization. | Plant Foods Hum Nutr | 2026 | https://conductscience.org/library/papers/42420694 | PubMed |
| 42402538 | Applications of Recombinant DNA Technology in Medicine: A Comprehensive Review. | Mol Biotechnol | 2026 | https://conductscience.org/library/papers/42402538 | PubMed |
| 42350438 | Next-generation mRNA vaccines: strategies to overcome stability challenges. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/42350438 | PubMed |
| 42318580 | Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure. | Front Artif Intell | 2026 | https://conductscience.org/library/papers/42318580 | PubMed |
| 42226986 | The Use and Importance ofArtificial Intelligence in Vaccine Research, Development, and Production. | Arch Razi Inst | 2025 | https://conductscience.org/library/papers/42226986 | PubMed |
| 42217024 | AI-driven big data analysis and predictive modeling of infectious disease immunity: from correlates to causal, multiscale understanding. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42217024 | PubMed |
| 42201941 | Advancing poultry health: A meta-analysis of epitope-based and peptide-based vaccines against Avian Pathogenic E. coli with machine learning insights. | PLoS One | 2026 | https://conductscience.org/library/papers/42201941 | PubMed |
| 42181885 | Artificial intelligence for coordinating vaccine design, antiviral discovery, and real-world monitoring in the era of emerging and endemic viral threats. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42181885 | PubMed |
| 42115011 | Applications of artificial intelligence in nuclear medicine. | Z Med Phys | 2026 | https://conductscience.org/library/papers/42115011 | PubMed |
| 42095951 | An integrated AI-driven vaccine design process: a systematic review of workflows from generative design to translational prediction. | Immunol Res | 2026 | https://conductscience.org/library/papers/42095951 | PubMed |
| 42051590 | AI-driven discovery in protein science for immunology and infectious disease research. | Front Bioinform | 2026 | https://conductscience.org/library/papers/42051590 | PubMed |
| 42012184 | Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. | J Virol | 2026 | https://conductscience.org/library/papers/42012184 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39019262
GET https://conductscience.org/api/papers/v1/39019262/cited_by?page=2